Dosing and frequency are individualized and monitored for safety
Lecanemab (Leqembi), Biogen and Eisais Alzheimers drug approved in 2023, is building a patient base that could generate significant revenues if its clinical profile is confirmed in broader use
The moderate form can cause a build up of acid in the body (metabolic acidosis), which can lead to nausea, fatigue, and vomiting
Taking it first thing in the morning, at least 20 to 30 minutes before breakfast, is a common and effective routine
This is particularly true among sulfur-containing residues such as methionine and cysteine
discard if the solution is cloudy, discoloured, or contains visible particles